GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (NAS:MASI) » Definitions » Peter Lynch Fair Value

Masimo (Masimo) Peter Lynch Fair Value : $21.29 (As of Apr. 25, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Masimo Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Masimo's PEG is 1. Masimo's 5-Year TTM EBITDA Growth Rate is 7.34. Masimo's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $2.90. Therefore, the Peter Lynch Fair Value for today is $21.29.

As of today (2024-04-25), Masimo's share price is $133.5949. Masimo's Peter Lynch fair value is $21.29. Therefore, Masimo's Price to Peter Lynch Fair Value Ratio for today is 6.28.


The historical rank and industry rank for Masimo's Peter Lynch Fair Value or its related term are showing as below:

MASI' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.83   Med: 4.02   Max: 8.06
Current: 6.28


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Masimo was 8.06. The lowest was 0.83. And the median was 4.02.


MASI's Price-to-Peter-Lynch-Fair-Value is ranked worse than
94.5% of 200 companies
in the Medical Devices & Instruments industry
Industry Median: 1.635 vs MASI: 6.28

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Masimo Peter Lynch Fair Value Historical Data

The historical data trend for Masimo's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Masimo Peter Lynch Fair Value Chart

Masimo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.95 60.98 36.31 25.42 21.29

Masimo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.42 22.20 25.43 24.23 21.29

Competitive Comparison of Masimo's Peter Lynch Fair Value

For the Medical Devices subindustry, Masimo's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Masimo's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Masimo's Price-to-Peter-Lynch-Fair-Value falls into.



Masimo Peter Lynch Fair Value Calculation

Masimo's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 7.34 *2.9
=21.29

Masimo's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.90.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Masimo  (NAS:MASI) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 7.34 instead of 15 in this case.

Masimo's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=133.5949/21.29
=6.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Masimo Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Masimo's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Masimo (Masimo) Business Description

Traded in Other Exchanges
Address
52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Executives
Rolf A Classon director C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Politan Capital Management Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Partners Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Quentin Koffey other: Director by deputization POLITAN CAPITAL MANAGEMENT LP, 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Management Lp other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Michelle Brennan director 1855 S. GRANT STREET, SAN MATEO CA 94402
Joe E Kiani director, officer: CEO and Chairman of the Board 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Hataishi officer: SVP, Chief Accounting Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Blair Tripodi officer: COO, Consumer Division C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Kevin P Duffy officer: President, Consumer 1 VIPER WAY, VISTA CA 92081
Adam Mikkelson director C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Tao Levy officer: EVP BUS DEV C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Micah W Young officer: EVP & Chief Financial Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Thomas Samuel Mcclenahan officer: EVP & GENERAL COUNSEL 40 PARKER, IRVINE CA 92618
Craig B Reynolds director 1046 MIDDLEBROOK WAY, KENESAW GA 30144

Masimo (Masimo) Headlines

From GuruFocus